Update on eosinophilic lung diseases

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 5, 2012, Pages 555-571

  Bhatt, Nitiny ^a   Allen, Jamesn ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

allergic bronchopulmonary aspergillosis; bronchocentric granulomatosis; Churg Strauss syndrome; eosinophil; eosinophilic pneumonia; hypereosinophilic syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AMIODARONE; AZATHIOPRINE; BLEOMYCIN; BRONCHODILATING AGENT; BUSULFAN; CAPTOPRIL; CARBAMAZEPINE; CLADRIBINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; GOLD; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IMATINIB; ITRACONAZOLE; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; NITROFURANTOIN; PENICILLAMINE; PHENYTOIN; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; UNINDEXED DRUG; VINCRISTINE;

ACUTE DISEASE; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASTHMA; BRONCHOSCOPY; CHRONIC DISEASE; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CYSTIC FIBROSIS; EOSINOPHIL; EOSINOPHILIA; EOSINOPHILIC LUNG DISEASE; HUMAN; HYPEREOSINOPHILIC SYNDROME; LABORATORY TEST; LOEFFLER PNEUMONIA; LUNG BIOPSY; LUNG DISEASE; LUNG FUNCTION TEST; LUNG GRANULOMATOSIS; LUNG LAVAGE; MYCOSIS; PARASITOSIS; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

BIOPSY; BRONCHOSCOPY; EOSINOPHILIA; HUMANS; LUNG DISEASES; PULMONARY EOSINOPHILIA;

EID: 84866489271     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1325164     Document Type: Article

References (171)

1. Wenzel S. E., Schwartz L. B., Langmack E. L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med: 1999; 160 3 1001 1008 (Pubitemid 29442043)
2. Brightling C. E., Ward R., Goh K. L., Wardlaw A. J., Pavord I. D. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med: 1999; 160 2 406 410 (Pubitemid 29380649)
3. Allen J. N., Davis W. B. Eosinophilic lung diseases. Am J Respir Crit Care Med: 1994; 150 5 Pt 1 1423 1438 (Pubitemid 24356662)
4. Blanchard C., Rothenberg M. E. Biology of the eosinophil. Adv Immunol: 2009; 101 81 121
5. Ponath P. D., Qin S., Post T. W., et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med: 1996; 183 6 2437 2448 (Pubitemid 26192353)
6. Gotlib J. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol: 2011; 86 8 677 688
7. Simon D., Simon H. U. Eosinophilic disorders. J Allergy Clin Immunol: 2007; 119 6 1291 1300, quiz 13011302 (Pubitemid 46855844)
8. Allen J. N., Davis W. B., Pacht E. R. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis: 1990; 142 3 642 647 (Pubitemid 20292729)
9. Allen J. NDW. Eosinophils. Philadelphia, PA Lippincott-Raven: 1997
10. Löffler W. Zur differential-diagnose der lungeninfiltrierungen, II: Über flüchtige succedan-inflitrate (mit eosinophilie). Beitr Klin Tuberk: 1932; 79 368 392
11. Ford R. M. Transient pulmonary eosinophilia and asthma. A review of 20 cases occurring in 5,702 asthma sufferers. Am Rev Respir Dis: 1966; 93 5 797 803
12. Christoforidis A. J., Molnar W. Eosinophilic pneumonia. Report of two cases with pulmonary biopsy. JAMA: 1960; 173 157 161
13. Carrington C. B., Addington W. W., Goff A. M., et al. Chronic eosinophilic pneumonia. N Engl J Med: 1969; 280 15 787 798
14. Jederlinic P. J., Sicilian L., Gaensler E. A. Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore): 1988; 67 3 154 162
15. Marchand E., Reynaud-Gaubert M., Lauque D., Durieu J., Tonnel A. B., Cordier J. F. Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelineso" Pulmonaires (GERMo"Oo"P). Medicine (Baltimore): 1998; 77 5 299 312
16. Gaensler E. A., Carrington C. B. Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema. AJR Am J Roentgenol: 1977; 128 1 1 13 (Pubitemid 8019847)
17. Johkoh T., Müller N. L., Akira M., et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology: 2000; 216 3 773 780 (Pubitemid 30660853)
18. Arakawa H., Kurihara Y., Niimi H., Nakajima Y., Johkoh T., Nakamura H. Bronchiolitis obliterans with organizing pneumonia versus chronic eosinophilic pneumonia: high-resolution CT findings in 81 patients. AJR Am J Roentgenol: 2001; 176 4 1053 1058 (Pubitemid 32240964)
19. Samman Y. S., Wali S. O., Abdelaal M. A., Gangi M. T., Krayem A. B. Chronic eosinophilic pneumonia presenting with recurrent massive bilateral pleural effusion: case report. Chest: 2001; 119 3 968 970 (Pubitemid 32197676)
20. Liebow A. A., Carrington C. B. The eosinophilic pneumonias. Medicine (Baltimore): 1969; 48 4 251 285
21. Kanner R. E., Hammar S. P. Chronic eosinophilic pneumonia. Ultrastructural evidence of marked immunoglobulin production plus macrophagic ingestion of eosinophils and eosinophilic lysosomes leading to intracytoplasmic Charcot-Leyden crystals. Chest: 1977; 71 1 95 98
22. Shijubo N., Fujishima T., Morita S., et al. Idiopathic chronic eosinophilic pneumonia associated with noncaseating epithelioid granulomas. Eur Respir J: 1995; 8 2 327 330
23. Cooney T. P. Interrelationship of chronic eosinophilic pneumonia, bronchiolitis obliterans, and rheumatoid disease: a hypothesis. J Clin Pathol: 1981; 34 2 129 137 (Pubitemid 11044229)
24. Olopade C. O., Crotty T. B., Douglas W. W., Colby T. V., Sur S. Chronic eosinophilic pneumonia and idiopathic bronchiolitis obliterans organizing pneumonia: comparison of eosinophil number and degranulation by immunofluorescence staining for eosinophil-derived major basic protein. Mayo Clin Proc: 1995; 70 2 137 142
25. Katzenstein A. L. Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. A review. Am J Clin Pathol: 2000; 114 5 767 772
26. Lai R. S., Lin S. L., Lai N. S., Lee P. C. Churg-Strauss syndrome presenting with pulmonary capillaritis and diffuse alveolar hemorrhage. Scand J Rheumatol: 1998; 27 3 230 232
27. Basset F., Ferrans V. J., Soler P., Takemura T., Fukuda Y., Crystal R. G. Intraluminal fibrosis in interstitial lung disorders. Am J Pathol: 1986; 122 3 443 461 (Pubitemid 16017665)
28. Phunmanee A., Boonsawat W., Charoensiri D. J., Limkunacul C. Chronic eosinophilic pneumonia: a case report. J Med Assoc Thai: 2000; 83 8 959 963
29. Fox B., Seed W. A. Chronic eosinophilic pneumonia. Thorax: 1980; 35 8 570 580 (Pubitemid 10055761)
30. Perrault J. L., Janis M., Wolinsky H. Resolution of chronic eosinophilic pneumonia with corticoid therapy: demonstration by needle biopsy. Ann Intern Med: 1971; 74 6 951 954
31. Allen J. N., Pacht E. R., Gadek J. E., Davis W. B. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med: 1989; 321 9 569 574 (Pubitemid 19212868)
32. Badesch D. B., King T. E. Jr, Schwarz M. I. Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am Rev Respir Dis: 1989; 139 1 249 252 (Pubitemid 19030453)
33. Hayakawa H., Sato A., Toyoshima M., Imokawa S., Taniguchi M. A clinical study of idiopathic eosinophilic pneumonia. Chest: 1994; 105 5 1462 1466 (Pubitemid 24152606)
34. Pope-Harman A. L., Davis W. B., Allen E. D., Christoforidis A. J., Allen J. N. Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore): 1996; 75 6 334 342 (Pubitemid 27009235)
35. Shintani H., Fujimura M., Ishiura Y., Noto M. A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance. Chest: 2000; 117 1 277 279 (Pubitemid 30053652)
36. Uchiyama H., Suda T., Nakamura Y., et al. Alterations in smoking habits are associated with acute eosinophilic pneumonia. Chest: 2008; 133 5 1174 1180 (Pubitemid 351685523)
37. Glazer C. S., Cohen L. B., Schwarz M. I. Acute eosinophilic pneumonia in AIDS. Chest: 2001; 120 5 1732 1735 (Pubitemid 33078497)
38. Rom W. N., Weiden M., Garcia R., et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med: 2002; 166 6 797 800
39. Shorr A. F., Scoville S. L., Cersovsky S. B., et al. Acute eosinophilic pneumonia among US Military personnel deployed in or near Iraq. JAMA: 2004; 292 24 2997 3005 (Pubitemid 39665301)
40. Trawick D., Kotch A., Matthay R., Homer R. J. Eosinophilic pneumonia as a presentation of occult chronic granulomatous disease. Eur Respir J: 1997; 10 9 2166 2170 (Pubitemid 27406460)
41. Maeno T., Maeno Y., Sando Y., et al. Nuclear hypersegmentation precedes the increase in blood eosinophils in acute eosinophilic pneumonia. Intern Med: 2000; 39 2 157 159
42. Ogawa H., Fujimura M., Matsuda T., Nakamura H., Kumabashiri I., Kitagawa S. Transient wheeze. Eosinophilic bronchobronchiolitis in acute eosinophilic pneumonia. Chest: 1993; 104 2 493 496 (Pubitemid 23229522)
43. King M. A., Pope-Harman A. L., Allen J. N., Christoforidis G. A., Christoforidis A. J. Acute eosinophilic pneumonia: radiologic and clinical features. Radiology: 1997; 203 3 715 719 (Pubitemid 27227419)
44. Philit F., Etienne-Mastroïanni B., Parrot A., Guérin C., Robert D., Cordier J. F. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med: 2002; 166 9 1235 1239 (Pubitemid 35222601)
45. Ricker D. H., Taylor S. R., Gartner J. C. Jr, Kurland G. Fatal pulmonary aspergillosis presenting as acute eosinophilic pneumonia in a previously healthy child. Chest: 1991; 100 3 875 877
46. Tazelaar H. D., Linz L. J., Colby T. V., Myers J. L., Limper A. H. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med: 1997; 155 1 296 302 (Pubitemid 27053180)
47. Churg J., Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol: 1951; 27 2 277 301
48. Chumbley L. C., Harrison E. G. Jr, DeRemee R. A. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc: 1977; 52 8 477 484 (Pubitemid 8161397)
49. Lanham J. G., Elkon K. B., Pusey C. D., Hughes G. R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore): 1984; 63 2 65 81 (Pubitemid 14166819)
50. Guillevin L., Cohen P., Gayraud M., Lhote F., Jarrousse B., Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore): 1999; 78 1 26 37 (Pubitemid 29065978)
51. Churg A. Recent advances in the diagnosis of Churg-Strauss syndrome. Mod Pathol: 2001; 14 12 1284 1293 (Pubitemid 33151172)
52. Keogh K. A., Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med: 2003; 115 4 284 290 (Pubitemid 37088190)
53. Sablé-Fourtassou R., Cohen P., Mahr A., et al. French Vasculitis Study Group Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med: 2005; 143 9 632 638 (Pubitemid 41552527)
54. Mouthon L., Le Toumelin P., Andre M. H., Gayraud M., Casassus P., Guillevin L. Polyarteritis nodosa and Churg-Strauss angiitis: characteristics and outcome in 38 patients over 65 years. Medicine (Baltimore): 2002; 81 1 27 40 (Pubitemid 34081285)
55. Neumann T., Manger B., Schmid M., et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore): 2009; 88 4 236 243
56. Churg J. Allergic granulomatosis and granulomatous-vascular syndromes. Ann Allergy: 1963; 21 619 628
57. Sale S., Patterson R. Recurrent Churg-Strauss vasculitis: with exophthalmos, hearing loss, nasal obstruction, amyloid deposits, hyperimmunoglobulinemia E, and circulating immune complexes. Arch Intern Med: 1981; 141 10 1363 1365
58. Wechsler M. E., Garpestad E., Flier S. R., et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA: 1998; 279 6 455 457 (Pubitemid 28082256)
59. Hauser T., Mahr A., Metzler C., et al. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax: 2008; 63 8 677 682
60. Wechsler M. E., Pauwels R., Drazen J. M. Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal? Drug Saf: 1999; 21 4 241 251
61. Puéchal X., Rivereau P., Vinchon F. Churg-Strauss syndrome associated with omalizumab. Eur J Intern Med: 2008; 19 5 364 366 (Pubitemid 351783388)
62. Wechsler M. E., Wong D. A., Miller M. K., Lawrence-Miyasaki L. Churg-strauss syndrome in patients treated with omalizumab. Chest: 2009; 136 2 507 518
63. Goeken J. A. Antineutrophil cytoplasmic antibodya useful serological marker for vasculitis. J Clin Immunol: 1991; 11 4 161 174
64. Sinico R. A., Di Toma L., Maggiore U., et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum: 2005; 52 9 2926 2935 (Pubitemid 41369124)
65. Olivieri D., Pesci A., Bertorelli G. Eosinophilic alveolitis in immunologic interstitial lung disorders. Lung: 1990; 168 Suppl 964 973 (Pubitemid 20217753)
66. Cottin V., Khouatra C., Dubost R., Glérant J. C., Cordier J. F. Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up. Allergy: 2009; 64 4 589 595
67. Szczeklik W., Sokoowska B. M., Zuk J., Mastalerz L., Szczeklik A., Musia J. The course of asthma in Churg-Strauss syndrome. J Asthma: 2011; 48 2 183 187
68. Cooper B. J., Bacal E., Patterson R. Allergic angiitis and granulomatosis: prolonged remission induced by combined prednisoneazathioprine therapy. Arch Intern Med: 1978; 138 3 367 371 (Pubitemid 9039472)
69. MacFadyen R., Tron V., Keshmiri M., Road J. D. Allergic angiitis of Churg and Strauss syndrome: response to pulse methylprednisolone. Chest: 1987; 91 4 629 631 (Pubitemid 17058897)
70. Conron M., Beynon H. L. Churg-Strauss syndrome. Thorax: 2000; 55 10 870 877
71. Guillevin L., Lhote F., Gayraud M., et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore): 1996; 75 1 17 28 (Pubitemid 26041085)
72. Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., Le Toumelin P.; French Vasculitis Study Group (FVSG). The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore): 2011; 90 1 19 27
73. Ribi C., Cohen P., Pagnoux C., et al. French Vasculitis Study Group Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum: 2008; 58 2 586 594 (Pubitemid 351294896)
74. Cohen P., Pagnoux C., Mahr A., et al. French Vasculitis Study Group Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum: 2007; 57 4 686 693 (Pubitemid 46764061)
75. Guillevin L., Fain O., Lhote F., et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum: 1992; 35 2 208 215
76. Tatsis E., Schnabel A., Gross W. L. Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med: 1998; 129 5 370 374 (Pubitemid 28402791)
77. Jones R. B., Tervaert J. W., Hauser T., et al. European Vasculitis Study Group Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med: 2010; 363 3 211 220
78. Stone J. H., Merkel P. A., Spiera R., et al. RAVE-ITN Research Group Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med: 2010; 363 3 221 232
79. Cartin-Ceba R., Keogh K. A., Specks U., Sethi S., Fervenza F. C. Rituximab for the treatment of Churg-Strauss syndrome with renal involvement. Nephrol Dial Transplant: 2011; 26 9 2865 2871
80. Donvik K. K., Omdal R. Churg-Strauss syndrome successfully treated with rituximab. Rheumatol Int: 2011; 31 1 89 91
81. Chusid M. J., Dale D. C., West B. C., Wolff S. M. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore): 1975; 54 1 1 27
82. Fauci A. S., Harley J. B., Roberts W. C., Ferrans V. J., Gralnick H. R., Bjornson B. H. NIH conference: the idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med: 1982; 97 1 78 92 (Pubitemid 12091287)
83. Klion A. D., Bochner B. S., Gleich G. J., et al. The Hypereosinophilic Syndromes Working Group Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol: 2006; 117 6 1292 1302 (Pubitemid 43795762)
84. Ogbogu P. U., Bochner B. S., Butterfield J. H., et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol: 2009; 124 6 1319 1325, e3
85. Cogan E., Schandené L., Crusiaux A., Cochaux P., Velu T., Goldman M. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med: 1994; 330 8 535 538 (Pubitemid 24058956)
86. Raghavachar A., Fleischer S., Frickhofen N., Heimpel H., Fleischer B. T lymphocyte control of human eosinophilic granulopoiesis: clonal analysis in an idiopathic hypereosinophilic syndrome. J Immunol: 1987; 139 11 3753 3758 (Pubitemid 18013653)
87. Roufosse F., Schandené L., Sibille C., et al. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol: 2000; 109 3 540 548 (Pubitemid 30415180)
88. Simon H. U., Plötz S. G., Dummer R., Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med: 1999; 341 15 1112 1120 (Pubitemid 29466223)
89. Spry C. J., Davies J., Tai P. C., Olsen E. G., Oakley C. M., Goodwin J. F. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med: 1983; 52 205 1 22 (Pubitemid 14248195)
90. Parrillo J. E., Borer J. S., Henry W. L., Wolff S. M., Fauci A. S. The cardiovascular manifestations of the hypereosinophilic syndrome: prospective study of 26 patients, with review of the literature. Am J Med: 1979; 67 4 572 582 (Pubitemid 10249294)
91. Dulohery M. M., Patel R. R., Schneider F., Ryu J. H. Lung involvement in hypereosinophilic syndromes. Respir Med: 2011; 105 1 114 121
92. Spry C. J. The hypereosinophilic syndrome: clinical features, laboratory findings and treatment. Allergy: 1982; 37 8 539 551 (Pubitemid 13238961)
93. Bain B. J., Fletcher S. H. Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome. Immunol Allergy Clin North Am: 2007; 27 3 377 388 (Pubitemid 47381568)
94. Klion A. Hypereosinophilic syndrome: current approach to diagnosis and treatment. Annu Rev Med: 2009; 60 293 306
95. Slabbynck H., Impens N., Naegels S., Dewaele M., Schandevyl W. Idiopathic hypereosinophilic syndrome-related pulmonary involvement diagnosed by bronchoalveolar lavage. Chest: 1992; 101 4 1178 1180
96. Winn R. E., Kollef M. H., Meyer J. I. Pulmonary involvement in the hypereosinophilic syndrome. Chest: 1994; 105 3 656 660 (Pubitemid 24088436)
97. Kang E. Y., Shim J. J., Kim J. S., Kim K. I. Pulmonary involvement of idiopathic hypereosinophilic syndrome: CT findings in five patients. J Comput Assist Tomogr: 1997; 21 4 612 615 (Pubitemid 27432702)
98. Zielinski R. M., Lawrence W. D. Interferon-alpha for the hypereosinophilic syndrome. Ann Intern Med: 1990; 113 9 716 718
99. Smit A. J., van Essen L. H., de Vries E. G. Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide. Cancer: 1991; 67 11 2826 2827
100. Butterfield J. H., Gleich G. J. Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa. J Allergy Clin Immunol: 1994; 94 6 Pt 2 1318 1326
101. Hirashima M., Ueno M., Kamiya K., Higuchi S., Matsumoto R. Functional heterogeneity of human eosinophil chemotactic lymphokines. Lymphokine Cytokine Res: 1991; 10 6 481 486
102. Masunaga T., Tatsumi Y., Miyamori I., Ueno T., Takeda R. A case report of the hypereosinophilic syndrome with eosinophilic peritonitis, revealing abnormal imagings of the liver scintigram and brain computed tomography [in Japanese]. Nippon Naika Gakkai Zasshi: 1989; 78 5 666 671
103. Qazilbash M. H., Ueno N. T., Hosing C., et al. Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation. Bone Marrow Transplant: 2006; 38 5 393 394
104. Sato Y., Matsumoto T., Ueno N., Ohkawa M., Tono-oka T., Takeda T. A case of hypereosinophilic syndrome associated with childhood ALL [in Japanese]. Rinsho Ketsueki: 1982; 23 12 1895 1901
105. Tono-oka T., Sato Y., Matsumoto T., et al. Hypereosinophilic syndrome in acute lymphoblastic leukemia with a chromosome translocation [t(5q;14q)]. Med Pediatr Oncol: 1984; 12 1 33 37 (Pubitemid 14155823)
106. Ueno N. T., Anagnostopoulos A., Rondón G., et al. Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. Br J Haematol: 2002; 119 1 131 134 (Pubitemid 35176512)
107. Ueno N. T., Zhao S., Robertson L. E., Consoli U., Andreeff M. 2-Chlorodeoxyadenosine therapy for idiopathic hypereosinophilic syndrome. Leukemia: 1997; 11 8 1386 1390 (Pubitemid 27387322)
108. Zabel P., Schlaak M. Cyclosporin for hypereosinophilic syndrome. Ann Hematol: 1991; 62 6 230 231
109. Fukushima T., Kuriyama K., Ito H., et al. Successful bone marrow transplantation for idiopathic hypereosinophilic syndrome. Br J Haematol: 1995; 90 1 213 215
110. Sigmund D. A., Flessa H. C. Hypereosinophilic syndrome: successful allogeneic bone marrow transplantation. Bone Marrow Transplant: 1995; 15 4 647 648
111. Hinson K. F., Moon A. J., Plummer N. S. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax: 1952; 7 4 317 333
112. Rosenberg M., Patterson R., Mintzer R., Cooper B. J., Roberts M., Harris K. E. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med: 1977; 86 4 405 414 (Pubitemid 8078948)
113. Vlahakis N. E., Aksamit T. R. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc: 2001; 76 9 930 938 (Pubitemid 32825915)
114. Patterson R., Greenberger P. A., Radin R. C., Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med: 1982; 96 3 286 291 (Pubitemid 12187503)
115. Patterson R., Greenberger P. A., Lee T. M., et al. Prolonged evaluation of patients with corticosteroid-dependent asthma stage of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol: 1987; 80 5 663 668 (Pubitemid 18027706)
116. Capewell S., Chapman B. J., Alexander F., Greening A. P., Crompton G. K. Corticosteroid treatment and prognosis in pulmonary eosinophilia. Thorax: 1989; 44 11 925 929 (Pubitemid 19281534)
117. Mastella G., Rainisio M., Harms H. K., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J: 2001; 17 5 1052 1053 (Pubitemid 32600355)
118. Geller D. E., Kaplowitz H., Light M. J., Colin A. A. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Chest: 1999; 116 3 639 646
119. Egan J. J., Yonan N., Carroll K. B., Deiraniya A. K., Webb A. K., Woodcock A. A. Allergic bronchopulmonary aspergillosis in lung allograft recipients. Eur Respir J: 1996; 9 1 169 171
120. Lebecque P., Pepermans X., Marchand E., Leonard A., Leal T. ABPA in adulthood: a CFTR-related disorder. Thorax: 2011; 66 6 540 541
121. Marchand E., Verellen-Dumoulin C., Mairesse M., et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest: 2001; 119 3 762 767 (Pubitemid 32197645)
122. Chauhan B., Santiago L., Hutcheson P. S., et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol: 2000; 106 4 723 729
123. Ricketti A. J., Greenberger P. A., Patterson R. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol: 1984; 74 1 68 71 (Pubitemid 14093028)
124. Krasnick J., Greenberger P. A., Roberts M., Patterson R. Allergic bronchopulmonary aspergillosis: serologic update for 1995. J Clin Lab Immunol: 1995; 46 3 137 142
125. McCarthy D. S., Simon G., Hargreave F. E. The radiological appearances in allergic broncho-pulmonary aspergillosis. Clin Radiol: 1970; 21 4 366 375
126. Mitchell T. A., Hamilos D. L., Lynch D. A., Newell J. D. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis (ABPA). J Asthma: 2000; 37 1 65 72 (Pubitemid 30111904)
127. Ward S., Heyneman L., Lee M. J., Leung A. N., Hansell D. M., Müller N. L. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol: 1999; 173 4 937 942 (Pubitemid 29451289)
128. Patterson R., Greenberger P. A., Halwig J. M., Liotta J. L., Roberts M. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med: 1986; 146 5 916 918 (Pubitemid 16116672)
129. Franquet T., Müller N. L., Giménez A., Guembe P., de La Torre J., Bagué S. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics: 2001; 21 4 825 837 (Pubitemid 33707878)
130. Ward S., Heyneman L. E., Flint J. D., Leung A. N., Kazerooni E. A., Müller N. L. Bronchocentric granulomatosis: computed tomographic findings in five patients. Clin Radiol: 2000; 55 4 296 300 (Pubitemid 32062976)
131. Slavin R. G., Bedrossian C. W., Hutcheson P. S., et al. A pathologic study of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol: 1988; 81 4 718 725
132. Bosken C. H., Myers J. L., Greenberger P. A., Katzenstein A. L. Pathologic features of allergic bronchopulmonary aspergillosis. Am J Surg Pathol: 1988; 12 3 216 222 (Pubitemid 18085206)
133. Imbeault B., Cormier Y. Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis. Chest: 1993; 103 5 1614 1617 (Pubitemid 23145638)
134. Seaton A., Seaton R. A., Wightman A. J. Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids: a fifteen-year follow-up. QJM: 1994; 87 9 529 537 (Pubitemid 24289823)
135. Salez F., Brichet A., Desurmont S., Grosbois J. M., Wallaert B., Tonnel A. B. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest: 1999; 116 6 1665 1668 (Pubitemid 30012710)
136. Stevens D. A., Schwartz H. J., Lee J. Y., et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med: 2000; 342 11 756 762 (Pubitemid 30151919)
137. Wark P. A., Gibson P. G., Wilson A. J. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev: 2004; 3 CD001108
138. Wark P. A., Hensley M. J., Saltos N., et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol: 2003; 111 5 952 957 (Pubitemid 36570853)
139. Liebow A. A. The J. Burns Amberson lecturepulmonary angiitis and granulomatosis. Am Rev Respir Dis: 1973; 108 1 1 18
140. Robinson R. G., Wehunt W. D., Tsou E., Koss M. N., Hochholzer L. Bronchocentric granulomatosis: roentgenographic manifestations. Am Rev Respir Dis: 1982; 125 6 751 756 (Pubitemid 12074594)
141. Katzenstein A. L., Liebow A. A., Friedman P. J. Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. Am Rev Respir Dis: 1975; 111 4 497 537
142. Wiedemann H. P., Bensinger R. E., Hudson L. D. Bronchocentric granulomatosis with eye involvement. Am Rev Respir Dis: 1982; 126 2 347 350 (Pubitemid 12047102)
143. Gelpi A. P., Mustafa A. Ascaris pneumonia. Am J Med: 1968; 44 3 377 389
144. Ambrus J. L., Klein E. Löffler syndrome and ancylostomiasis brasiliensis. N Y State J Med: 1988; 88 9 498 499
145. Ong R. K., Doyle R. L. Tropical pulmonary eosinophilia. Chest: 1998; 113 6 1673 1679 (Pubitemid 28307176)
146. Cooray J. H., Ismail M. M. Re-examination of the diagnostic criteria of tropical pulmonary eosinophilia. Respir Med: 1999; 93 9 655 659 (Pubitemid 29476256)
147. Lombard C. M., Tazelaar H. D., Krasne D. L. Pulmonary eosinophilia in coccidioidal infections. Chest: 1987; 91 5 734 736 (Pubitemid 17069174)
148. Acute Eosinophilic Pneumonia. N Engl J Med: 1990; 322 9 634 636
149. Fleury-Feith J., Van Nhieu J. T., Picard C., Escudier E., Bernaudin J. F. Bronchoalveolar lavage eosinophilia associated with Pneumocystis carinii pneumonitis in AIDS patients. Comparative study with non-AIDS patients. Chest: 1989; 95 6 1198 1201 (Pubitemid 19160139)
150. Kaufman L. D., Seidman R. J., Gruber B. L. L-tryptophan-associated eosinophilic perimyositis, neuritis, and fasciitis: a clinicopathologic and laboratory study of 25 patients. Medicine (Baltimore): 1990; 69 4 187 199 (Pubitemid 20225987)
151. Philen R. M., Hill R. H. Jr, Flanders W. D., et al. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico. Am J Epidemiol: 1993; 138 3 154 159 (Pubitemid 23253932)
152. Kamb M. L., Murphy J. J., Jones J. L., et al. Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients. JAMA: 1992; 267 1 77 82
153. Swygert L. A., Maes E. F., Sewell L. E., Miller L., Falk H., Kilbourne E. M. Eosinophilia-myalgia syndrome. Results of national surveillance. JAMA: 1990; 264 13 1698 1703 (Pubitemid 20324352)
154. Alonso-Ruiz A., Calabozo M., Perez-Ruiz F., Mancebo L. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Medicine (Baltimore): 1993; 72 5 285 295 (Pubitemid 23360476)
155. Davis W. B., Fells G. A., Sun X. H., Gadek J. E., Venet A., Crystal R. G. Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix: a possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract. J Clin Invest: 1984; 74 1 269 278 (Pubitemid 14086069)
156. Watters L. C., Schwarz M. I., Cherniack R. M., et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis: 1987; 135 3 696 704 (Pubitemid 17041608)
157. Rudd R. M., Haslam P. L., Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis: 1981; 124 1 1 8 (Pubitemid 11079332)
158. Hällgren R., Bjermer L., Lundgren R., Venge P. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis: signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis: 1989; 139 2 373 377 (Pubitemid 19057411)
159. Peterson M. W., Monick M., Hunninghake G. W. Prognostic role of eosinophils in pulmonary fibrosis. Chest: 1987; 92 1 51 56 (Pubitemid 17101335)
160. Yousem S. A. Eosinophilic pneumonia-like areas in idiopathic usual interstitial pneumonia. Mod Pathol: 2000; 13 12 1280 1284 (Pubitemid 32014664)
161. Friedman P. J., Liebow A. A., Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore): 1981; 60 6 385 396 (Pubitemid 12207233)
162. Costabel U., Teschler H., Guzman J. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J: 1992; 5 7 791 797
163. Izumi T., Kitaichi M., Nishimura K., Nagai S. Bronchiolitis obliterans organizing pneumonia: clinical features and differential diagnosis. Chest: 1992; 102 3 715 719
164. Bartter T., Irwin R. S., Nash G., Balikian J. P., Hollingsworth H. H. Idiopathic bronchiolitis obliterans organizing pneumonia with peripheral infiltrates on chest roentgenogram. Arch Intern Med: 1989; 149 2 273 279 (Pubitemid 19058509)
165. Spry C. JF. Eosinophils: A Comprehensive Review, and Guide to the Scientific and Medical Literature. New York, NY Oxford University Press: 1988
166. Kawasaki A., Mizushima Y., Matsui S., Hoshino K., Yano S., Kitagawa M. A case of T-cell lymphoma accompanying marked eosinophilia, chronic eosinophilic pneumonia and eosinophilic pleural effusion. A case report. Tumori: 1991; 77 6 527 530
167. Tan A. M., Downie P. J., Ekert H. Hypereosinophilia syndrome with pneumonia in acute lymphoblastic leukaemia. Aust Paediatr J: 1987; 23 6 359 361 (Pubitemid 18035982)
168. Bentley H. P., Reardon A. E., Knoedler J. P., Krivit W. Eosinophilic leukemia: Report of a case, with review and classification. Am J Med: 1961; 30 2 310 322
169. Yoshimi M., Nannya Y., Watanabe T., et al. Acute eosinophilic pneumonia is a non-infectious lung complication after allogeneic hematopoietic stem cell transplantation. Int J Hematol: 2009; 89 2 244 248
170. Akhtari M., Langston A. A., Waller E. K., Gal A. A. Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients. Bone Marrow Transplant: 2009; 43 2 155 158
171. Paralkar V. R., Goradia A., Luger S. M., Loren A. W. Severe eosinophilia as a manifestation of acute graft-versus-host disease. Oncology: 2008; 75 3-4 134 136